Bio

Clinical Focus


  • Nephrology
  • Advanced chronic kidney disease
  • Hypertension
  • Peritoneal Dialysis
  • Home Hemodialysis
  • Prolonged nocturnal dialysis

Academic Appointments


Administrative Appointments


  • Medical Director, WellBound San Jose (2015 - Present)
  • Director, Medical Clinical Affairs, Satellite Healthcare (2015 - Present)

Honors & Awards


  • Clinical Scientist in Nephrology Fellow, American Kidney Fund (2011)

Boards, Advisory Committees, Professional Organizations


  • Member, International Society of Peritoneal Dialysis (2016 - Present)
  • Member, American Society of Nephrology (2014 - Present)

Professional Education


  • Fellowship:Stanford University Nephrology Fellowship (2012) CA
  • Medical Education:University of California San Diego Medical School (2006) CA
  • Board Certification: Nephrology, American Board of Internal Medicine (2012)
  • Residency:UCSD Internal Medicine Program (2010) CA
  • Board Certification: Internal Medicine, American Board of Internal Medicine (2009)

Research & Scholarship

Clinical Trials


  • The EvAluation of TaBlo In-CLinic and In-HOme Recruiting

    The purpose of this study is to evaluate the Tablo Hemodialysis System when used In-Center by trained individuals and In-Home by trained Subjects.

    View full details

Publications

All Publications


  • Timing of initiation of dialysis: time for a new direction? CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION Abra, G., Tamura, M. K. 2012; 21 (3): 329-333

    Abstract

    The past 15 years have seen tremendous growth in the initiation of dialysis at higher levels of kidney function in the setting of mixed evidence and at great societal economic cost. We review recent data on the early dialysis initiation trend, the clinical and economic impact of early dialysis initiation and the future implications for the management of advanced chronic kidney disease (CKD).The percentage of patients who initiate dialysis with an estimated glomerular filtration rate (eGFR) above 10  ml/min/1.73m(2) is now greater than 50%, including 20% who initiate with an eGFR above 15 ml/min/1.73m(2). The drivers behind these findings are probably diverse but recent literature does not seem to support a higher symptom burden among the ageing CKD population as the major cause. The Initiating Dialysis Early And Late (IDEAL) trial provides guidance on the safety of waiting for symptoms or lower levels of estimated glomerular filtration rate prior to beginning dialysis. In addition, economic analyses based on the IDEAL and US Renal Data System findings suggest that significant cost savings could be achieved by reversing the early initiation trend.These findings should help clinicians and policy makers looking to rein in costs while maintaining the quality of CKD care.

    View details for DOI 10.1097/MNH.0b013e328351c244

    View details for Web of Science ID 000302769500014

    View details for PubMedID 22388556

  • Reversible hepatic and lipid abnormalities with nonprescription anabolic-androgenic steroid use in 2 HIV-infected men CLINICAL INFECTIOUS DISEASES Abra, G. E., Lonergan, J. T. 2006; 42 (1): 151-152

    View details for Web of Science ID 000233698900030

    View details for PubMedID 16323106